In the news
Consortium Including PathMaker Board Member, Prof. John Donoghue, Receives Sean M. Healey International Prize for Innovation in ALS for Pioneering Work on BCIs
MGH Sean M. Healey Center for ALS, December 2024
$2M grant supports new clinical trial of MyoRegulator for ALS
ALS News Today, June 2024
Presentation to EverythingALS group on PathMaker’s approach to ALS
EverythingALS, October 2023
PathMaker Launches First Human Trial to Test Non-invasive ALS Device
ALS News Today, September 2023
MDA Awards $600K to Support Neuromodulator in Slowing ALS
ALS News Today, January 2023
PathMaker Neurosystems Receives $600K From MDA for ALS Clinical Translational Studies
CSI Today, January 2023
London-based CERF Prizes Benefit US-based Research – PathMaker receives CERF Prize in ALS for Medical Electronics
ALS News Today, February 2022
Innovation is our DNA – PathMaker one of two companies highlighted by Choose Paris Region
Choose Paris Region, July 2020
PathMaker Neurosystems – Non-invasive Devices for the Treatment of Spasticity and ALS Without Drugs or Surgery
Praxis Spinal Cord Institute, June 2020
PathMaker Neurosystems Inc. – A Success Story of a Laureate of the YEi-Start in France Program
Office for Science & Technology of the Embassy of France in the United States, October 2019
Results From MyoRegulator for Spasticity Trial Published
Rehab Management, July 2019
Direct Nerve Stimulation using MyoRegulator System Seen to Reduce Spasticity in Mice with Spinal Cord Injury
Multiple Sclerosis News Today, February 2019
Pathmaker inks $5M deal to develop neuromodulation device for muscle spasticity
BioWorld MedTech, February 2018
MyoAmplifier Gets Seed Funding to Develop System for Pediatric Paralysis
Cerebral Palsy News Today, January 2018
BPIFrance Awards PathMaker Grant to Develop MyoRegulator, Device to Treat Spasticity
Multiple Sclerosis News Today, February 2017
Clinical Trial Begins for Device to Treat Spasticity in Cerebral Palsy, Other Disorders
Cerebral Palsy News Today, April 2016
PathMaker Launches Clinical Trial of MyoRegulator to Treat Spasticity, Common in MS
Multiple Sclerosis News Today, April 2016
Neuromodulator and artificial kidney to be reviewed under FDA’s Expedited Access Pathway
FierceMedicalDevices, November 2015
FDA speeds up approval process for PathMaker’s non-invasive medical device
Boston Business Journal, October 2015
PathMaker Neurosystems Inc. eyes European market with France expansion
Boston Business Journal, June 2015
Faculty Focus: New Frontiers in Rehabilitation
CUNY/CSI
A New Path to Mobility
CUNY video
New Treatment May Help Paralyzed Patients Move Again
NY1 News
Zaghloul Ahmed Awarded 2011 NYC Bioaccelerate Prize For Neural Stimulation System
CUNY